02 Sep One key thing to know about the new HRT study
Heard the recent news about the study that linked hormone replacement therapy (HRT) to a higher risk of breast cancer?(1)
Because of the complexities involved in research like this, I suspect this won’t be the last word on this issue. There may be other research that disputes this study, which is common with health research (as we all know from listening to researchers endlessly bounce back and forth about the health benefits and risks of margarine, real butter, saturated fat and cholesterol in food).
However, if you are looking for advice about whether HRT (either traditional or bio-identical) is right for you, I have one important piece of advice: Get more than one opinion. In fact, get more than three opinions.
And, most importantly, please have at least one of those opinions be from someone who does not benefit from you being on HRT–meaning someone who does not give you a prescription for it.
I’ve just read and heard a bunch of opinions from HRT providers minimizing this new research. These are not what I would consider impartial opinions. That’s because research like this could make some women decide HRT is not for them, which means less money for these doctors and other providers who give prescriptions. (I watched a video where one doctor who prescribes HRT say, “Breast cancer isn’t so bad.” Like many, I’ve unfortunately known women who succumbed to the disease, so I beg to differ.)
Please talk with your general practitioner or nurse practitioner (who knows your medical/family history and, therefore, your personal potential risks) and read the literature and articles about it yourself to find out if it’s right for you.
Never miss a Hormonology tip!
Subscribe to the free Hormonology newsletter:
I’d love to learn more–sign me up!
Learn how the hormones in your menstrual cycle impact you every day in my book, 28 Days: What Your Cycle Reveals About Your Moods, Health & Potential
(1) Valerie Beral, Richard Peto, Kirstin Pirie, Gillian Reeves, Joanne Kotsopoulos, “Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence,” The Lancet, August 29, 2019.